Safety of HES 130/0.4 (Voluven®) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: A prospective, randomized, controlled, parallel-group multicentre trial (European Journal of Anaesthesiology (2008) DOI: 10.1017/S026502150800447X);Safety of HES 130/0.4 (Voluven®) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: A prospective, randomized, controlled, parallel-group multicentre trial

European Journal of Anaesthesiology

Volumn 25, Issue 12, 2008, Pages 986-994

  Godet, G ^a,e   Lehot, J J ^b   Janvier, G ^c   Steib, A ^d   De Castro, V ^a   Coriat, P ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^e PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Chronic renal insufficiency; Gelatin; Hydroxyethyl starch; Postoperative acute renal failure; Surgery aortic

Indexed keywords

HETASTARCH; PLASMION;

ABDOMINAL AORTA; ACUTE KIDNEY FAILURE; ADULT; AGED; AMYLASE BLOOD LEVEL; ANEMIA; ANURIA; AORTA SURGERY; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTICENTER STUDY; OLIGURIA; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 55749085847     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021508004821     Document Type: Erratum

References (37)

1. Awad RW, Barham WJ, Taylor DN, Woodward DA, Bullen BR. The effect of infrarenal aortic reconstruction on glomerular filtration rate and effective renal plasma flow. Eur J Vasc Surg 1992; 6: 362-367.
2. Svensson LG, Coselli JS, Safi HJ, Hess KR, Crawford ES. Appraisal of adjuncts to prevent acute renal failure after surgery on the thoracic or thoracoabdominal aorta. J Vasc Surg 1989; 10: 230-239.
3. Svensson LG, Crawford ES, Hess KR, Coselli JS, Safi HJ. Experience with 1509 patients undergoing thoracoabdominal aortic operations. J Vasc Surg 1993; 17: 357-368; discussion 368-370.
4. Boldt J, Müller M, Mentges D, Papsdorf M. Hempelmann GVolume therapy in the critically ill: is there a difference? Intensive Care Med 1998; 24: 28-36.
5. Schortgen F, Deye N, Brochard L; CRYCO Study Group. Preferred plasma volume expanders for critically ill patients: results of an international survey. Intensive Care Med 2004; 30: 2222-2229.
6. Davidson IJ. Renal impact of fluid management with colloids: a comparative review. Eur J Anaesthesiol 2006; 23: 721-738.
7. Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med 1999; 25: 258-268.
8. Jungheinrich C, Neff TA. Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 2005; 44: 681-699.
9. Dieterich HJ. Recent developments in European colloid solutions. J Trauma 2003; 54: S26-S30.
10. Waitzinger J, Bepperling F, Pabst G, Opitz J. Hydroxyethyl starch (HES) 130/0.4, a new HES specification: pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers. Drugs R D 2003; 4: 149-157.
11. Waitzinger J, Bepperling F, Pabst B, Opitz J, Müller M, Baron JF. Pharmacokinetics and tolerability of a new hydroxyethyl starch (HES) specification [HES (130/0.4)] after single-dose infusion of 6% or 10% solutions in healthy volunteers. Clin Drug Invest 1998; 16: 151-160.
12. Jungheinrich C, Sauermann W, Bepperling F, Vogt NH. Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6%) with an optimised in vivo molecular weight in orthopaedic surgery: a randomised, double-blind study. Drugs R D 2004; 5: 1-9.
13. Gallandat Huet RC, Siemons AW, Baus D et al. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth 2000; 47: 1207-1215.
14. Langeron O, Doelberg M, Ang ET, Bonnet F, Capdevila X, Coriat P. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 2001; 92: 855-862.
15. Schortgen F, Lacherade JC, Bruneel F et al. Effects of hydroxyethyl starch and gelatin on renal function in severe sepsis: a multicentre randomized study. Lancet 2001; 357: 911-916.
16. Boldt J, Godet G, Bernal W, Wendon JA. Hydroxyethyl-starch as a risk factor for acute renal failure in severe sepsis. Lancet 2001; 358: 581-583.
17. Legendre C, Thervet E, Page B, Percheron A, Noel LH, Kreis H. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 1993; 342: 248-249.
18. Ebcioglu Z, Cohen DJ, Crew RJ et al. Osmotic nephrosis in a renal transplant recipient. Kidney Int 2006; 70: 1873-1876.
19. Boldt J, Brenner T, Lehmann A, Lang J, Kumle B, Werling C. Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of a new starch preparation with gelatin. Intensive Care Med 2003; 29: 763-769.
20. Jungheinrich C, Scharpf R, Wargenau M, Bepperling F. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild to severe renal impairment. Anesth Analg 2002; 95: 544-551.
21. Boldt J, Brosch C, Ducke M, Papsdorf M, Lehmann A. Influence of volume therapy with a modern hydroxyethyl-starch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. Crit Care Med 2007; 35: 2740-2746.
22. Lenz K, Schimetta W, Polz W, Kröll W, Gruy-Kapral C, Magometschnigg D. Intestinal elimination of hydroxyethyl starch? Intensive Care Med 2000; 26: 733-739.
23. Kumle B, Boldt J, Piper S, Schmidt C, Suttner S, Salopek S. The influence of different intravascular volume replacement regimens on renal function in the elderly. Anesth Analg 1999; 89: 1124-1130.
24. Cittanova ML, Mavre J, Riou B, Coriat P. Long-term follow-up of transplanted kidneys according to plasma volume expander of kidney donors. Intensive Care Med 2001; 27: 1830.
25. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996; 348: 1620-1622.
26. Pillebout E, Nochy D, Hill G et al. Renal histopathological lesions after orthotopic liver transplantation (OLT). Am J Transplant 2005; 5: 1120-1129.
27. Randhawa PS, Shapiro R. Chronic renal failure after liver transplantation. Am J Transplant 2005; 5: 967-968.
28. Winkelmayer WC, Glynn RJ, Levin R, Avorn J. Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int 2003; 64: 1046-1049.
29. Barron ME, Wilkes MM, Navickis RJ. A systematic review of the comparative safety of colloids. Arch Surg 2004; 139: 552-563.
30. Wiedermann CJ. Hydroxyethyl starch - can the safety problems be ignored? Wien Klin Wochenschr 2004; 116: 583-594.
31. Boldt J. Hydroxyethylstarch as a risk factor for acute renal failure: is a change of clinical practice indicated? Drug Saf 2002; 25: 837-846.
32. Leuschner J, Opitz J, Winkler A, Scharpf R, Bepperling F. Tissue storage of 14C-labeled hydroxyethyl starch (HES) 130/0.4 and HES 200/0.5 after repeated intravenous administration to rats. Drugs R D 2003; 4: 331-338.
33. Neff TA, Doelberg M, Jungheinrich C, Sauerland A, Spahn DR, Stocker R. Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg 2003; 96: 1453-1459.
34. Boldt J, Brenner T, Lang J, Kumle B, Isgro F. Kidney-specific proteins in elderly patients undergoing cardiac surgery with cardiopulmonary bypass. Anesth Analg 2003; 97: 1582-1589.
35. Suttner S, Boldt J. Volume replacement with hydroxyethyl starch: is there an influence on kidney function? Anasthesiol Intensivmed Notfallmed Schmerzther 2004; 39: 71-77.
36. Sakr Y, Payen D, Reinhart K et al. Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 2007; 98: 216-224.
37. Mahmood A, Gosling P, Vohra K. Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery. Br J Surgery 2007; 94: 427-433.